[HTML][HTML] NIA-AA research framework: toward a biological definition of Alzheimer's disease

CR Jack Jr, DA Bennett, K Blennow, MC Carrillo… - Alzheimer's & …, 2018 - Elsevier
Abstract In 2011, the National Institute on Aging and Alzheimer's Association created
separate diagnostic recommendations for the preclinical, mild cognitive impairment, and …

In vivo tau PET imaging in dementia: pathophysiology, radiotracer quantification, and a systematic review of clinical findings

B Hall, E Mak, S Cervenka, FI Aigbirhio, JB Rowe… - Ageing research …, 2017 - Elsevier
In addition to the deposition of β-amyloid plaques, neurofibrillary tangles composed of
aggregated hyperphosphorylated tau are one of the pathological hallmarks of Alzheimer's …

Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer's disease, frontotemporal dementia and progressive supranuclear …

L Chouliaras, A Thomas, M Malpetti… - Journal of Neurology …, 2022 - jnnp.bmj.com
Objectives This longitudinal study compared emerging plasma biomarkers for
neurodegenerative disease between controls, patients with Alzheimer's disease (AD), Lewy …

Myocardial inflammation predicts remodeling and neuroinflammation after myocardial infarction

JT Thackeray, HC Hupe, Y Wang, JP Bankstahl… - Journal of the American …, 2018 - jacc.org
Background: The local inflammatory tissue response after acute myocardial infarction (MI)
determines subsequent healing. Systemic interaction may induce neuroinflammation as a …

Neuroinflammation and functional connectivity in Alzheimer's disease: interactive influences on cognitive performance

L Passamonti, KA Tsvetanov, PS Jones… - Journal of …, 2019 - Soc Neuroscience
Neuroinflammation is a key part of the etio-pathogenesis of Alzheimer's disease (AD). We
tested the relationship between neuroinflammation and the disruption of functional …

Microglial activation and tau burden predict cognitive decline in Alzheimer's disease

M Malpetti, RA Kievit, L Passamonti, PS Jones… - Brain, 2020 - academic.oup.com
Tau pathology, neuroinflammation, and neurodegeneration are key aspects of Alzheimer's
disease. Understanding whether these features predict cognitive decline, alone or in …

Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy

TE Cope, T Rittman, RJ Borchert, PS Jones… - Brain, 2018 - academic.oup.com
Alzheimer's disease and progressive supranuclear palsy (PSP) represent
neurodegenerative tauopathies with predominantly cortical versus subcortical disease …

18F-AV-1451 positron emission tomography in Alzheimer's disease and progressive supranuclear palsy

L Passamonti, P Vázquez Rodríguez, YT Hong… - Brain, 2017 - academic.oup.com
The ability to assess the distribution and extent of tau pathology in Alzheimer's disease and
progressive supranuclear palsy in vivo would help to develop biomarkers for these …

Microglial activation in the frontal cortex predicts cognitive decline in frontotemporal dementia

M Malpetti, TE Cope, D Street, PS Jones… - Brain, 2023 - academic.oup.com
Frontotemporal dementia is clinically and neuropathologically heterogeneous, but
neuroinflammation, atrophy and cognitive impairment occur in all of its principal syndromes …

Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum

WR Bevan-Jones, TE Cope, PS Jones, SS Kaalund… - Brain, 2020 - academic.oup.com
The clinical syndromes of frontotemporal dementia are clinically and neuropathologically
heterogeneous, but processes such as neuroinflammation may be common across the …